- Oral presentation
- Open Access
Probiotics prevent necrotizing enterocolitis, sepsis and mortality in preterm infants: a multicenter analysis of more than 10,000 VLBW infants in German NICUs
© Denkel et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Preterm Infant
- Neonatal Intensive Care Unit
- Premature Birth
- Necrotizing Enterocolitis
- Risk Factor Analysis
Enteral supplementation of probiotics has been demonstrated to reduce the risk of severe necrotizing enterocolitis (NEC) and all-cause mortality in preterm infants.
This retrospective analysis aimed to assess the frequency of NEC and sepsis in preterm infants with birth weights less than 1,500 grams (VLBW infants), before and after the implementation of prophylactic enteral administration of probiotics in German neonatal intensive care units (NICUs).
This multicenter study is based on NEO-KISS, the German surveillance system for nosocomial infections in VLBW infants. All NICUs that implemented prophylactic enteral administration of probiotics with ≥ 2 strains for VLBW infants were included in the analysis. Data of VLBW infants that were admitted between 36 months before and 36 months after the implementation of probiotics were analyzed. Study period was 2004 – 2014. Interrupted time series analyses were applied to evaluate longitudinal effects of the exposition (probiotics) on the frequency of i) NEC, ii) sepsis and iii) all-cause mortality. Risk factor analyses included Cox proportional hazard regression estimating hazard ratios (HR) with 95 % confidence intervals (95 % CI).
The data of 10,890 VLBW infants - including 4,683 infants with a birth weight below 1,000 grams (ELBW infants) - from 44 neonatal departments were included in this study. Incidences of NEC and sepsis were 2.5 % (n = 274) and 15.0 % (n = 1631) in VLBW infants; 4.6 % (n = 215) and 24.2 % (n = 1133) in ELBW infants. The use of probiotics significantly reduced the risk of NEC (HR = 0.48; 95% CI = 0.39 – 0.62), all-cause mortality (HR = 0.60, 95 % CI = 0.44 – 0.83) and sepsis (HR = 0.89, 95 % CI = 0.81 – 0.98). The subgroup analysis in the ELBW infants cohort showed an even more pronounced positive effect of probiotics on NEC (HR = 0.48, 95 % CI = 0.36 – 0.64), all-cause mortality (HR = 0.59, 95 % CI = 0.41 – 0.84) and even sepsis (HR = 0.83, 95 % CI = 0.71 – 0.94).
This large multicenter study provides evidence that prophylactic enteral probiotics administration significantly reduces complications of premature birth. Routine probiotic prophylaxis should be added to clinical practice as soon as possible.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.